Pharma-Bio Serv, Inc. (PBSV) Financials
PBSV Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Jan. 31, 2026 | 13.5 billion | 3.3 billion |
| Oct. 31, 2025 | 13.7 million | 1.7 million |
| July 31, 2025 | 13.6 billion | 1.7 billion |
| April 30, 2025 | 13.9 million | 1.8 million |
PBSV Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Jan. 31, 2026 | -390.1 million | 8.6 million |
| Oct. 31, 2025 | 279316 | 4399 |
| July 31, 2025 | 236.5 million | 10.0 million |
| April 30, 2025 | -305848 | 10000 |
PBSV Net Income
No data available :(
PBSV Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Jan. 31, 2026 | 10.6 billion | - | - |
| Oct. 31, 2025 | 10.9 million | - | 28834 |
| July 31, 2025 | 10.7 billion | - | - |
| April 30, 2025 | 10.4 million | - | 113044 |
PBSV Shares Outstanding
PBSV Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Jan. 31, 2026 | 2411 | - | 816.9 million | - |
| Oct. 31, 2025 | 350 | - | 882207 | - |
| July 31, 2025 | - | - | 888.1 million | - |
| April 30, 2025 | 4258 | - | 917048 | - |
PBSV Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Jan. 31, 2026 | 2.3 billion | 1.6 billion |
| Oct. 31, 2025 | 2.1 million | 1.4 million |
| July 31, 2025 | 2.0 billion | 1.4 billion |
| April 30, 2025 | 2.4 million | 1.6 million |
PBSV
Price: $0.53
Dividend Yield: 15.00%
Forward Dividend Yield: 14.27%
Payout Ratio: 250.00%
Dividend Per Share: 0.08 USD
Earnings Per Share: -0.01 USD
P/E Ratio: -49
Exchange: OQB
Sector: Healthcare
Industry: Health Information Services
Country: United States
Volume: 44500
Market Capitalization: 11.5 million
Average Dividend Frequency: 1
Years Paying Dividends: 4